Eli Lilly Expands Zepbound Vial Options, Lowers Prices For 2.5 mg, 5 Mg Doses
benzinga.com/general/biotech/25/02/43938612/eli-lilly-expands-zepbound-vial-options-lowers-prices-for-25-mg-5-mg-doses
On Tuesday, Eli Lilly And Co (NYSE:LLY) launched 7.5 mg and 10 mg Zepbound (tirzepatide) single-dose vials, available for $499 with the new Zepbound Self Pay Journey Program. Eli Lilly also reduced the price of the 2.5 mg and 5 mg vials.
These new offerings are available exclusively…
This story appeared on benzinga.com, 2025-02-25 13:17:54.